Translational Development Acquisition (TDACW) Total Liabilities (2023 - 2026)

Translational Development Acquisition (TDACW) has reported Total Liabilities for 4 consecutive years, with $7.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities rose 23.2% year-over-year to $7.8 million; the trailing twelve-month figure through Jun 2026 stood at $7.8 million (up 23.2% YoY), and the FY2025 full-year result was $6.6 million, up 5.34% from the prior year.
• Total Liabilities grew to $7.8 million in Q2 2026 per TDACW's latest filing, from $6.9 million in the prior quarter.
• Across five years, Total Liabilities topped out at $7.8 million in Q2 2026 and bottomed at $509679.0 in Q4 2023.
• Historically, Total Liabilities has averaged $5.3 million across 4 years, with a median of $6.4 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities surged 1125.83% in 2024, then rose 5.34% in 2025.
• Over 4 years, Total Liabilities stood at $509679.0 in 2023, then soared by 1125.83% to $6.2 million in 2024, then advanced by 5.34% to $6.6 million in 2025, then climbed by 18.35% to $7.8 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $7.8 million, $6.9 million, and $6.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.